Aron D. Rosenberg - Brookline MA, US Laurent D. Gilles de Pelichy - Allston MA, US Daniel Egan - Ayer MA, US Aliassghar N. Tofighi - Waltham MA, US Dosuk D. Lee - Brookline MA, US
Assignee:
Etex Corporation - Cambridge MA
International Classification:
A61F 2/28 A61F 2/26
US Classification:
424426
Abstract:
Osteogenic bone implant compositions that approximate the chemical composition of natural bone are provided. The organic component of these implant compositions is osteoinductive despite the presence of the inorganic component and, further, is present in an amount sufficient to maximize the regenerative capabilities of the implant without compromising its formability and mechanical strength. The composition may be an osteoinductive powder, including demineralized bone matrix (DBM) particles, a calcium phosphate powder, and, optionally, a biocompatible cohesiveness agent. The powder may be combined with a physiologically-acceptable fluid to produce a formable, osteoinductive paste that self-hardens to form a poorly crystalline apatitic (PCA) calcium phosphate having significant compressive strength. The bone implant materials retain their cohesiveness when introduced at an implant site and are remodeled into bone in vivo. Methods for using these implant materials to repair damaged bone and a method of assaying the content of DBM particles, by weight, in a bone implant material are also provided.
Aron D. Rosenberg - Brookline MA, US Laurent D. Gilles de Pelichy - Allston MA, US Daniel Egan - Ayer MA, US Aliassghar N. Tofighi - Waltham MA, US Youngmi M. Lee - Scarsdale NY, US
Assignee:
Etex Corporation - Cambridge MA
International Classification:
A61F 2/28
US Classification:
424426
Abstract:
Osteogenic bone implant compositions that approximate the chemical composition of natural bone are provided. The organic component of these implant compositions is osteoinductive despite the presence of the inorganic component and, further, is present in an amount sufficient to maximize the regenerative capabilities of the implant without compromising its formability and mechanical strength. The composition may be an osteoinductive powder, including demineralized bone matrix (DBM) particles, a calcium phosphate powder, and, optionally, a biocompatible cohesiveness agent. The powder may be combined with a physiologically-acceptable fluid to produce a formable, osteoinductive paste that self-hardens to form a poorly crystalline apatitic (PCA) calcium phosphate having significant compressive strength. The bone implant materials retain their cohesiveness when introduced at an implant site and are remodeled into bone in vivo. Methods for using these implant materials to repair damaged bone and a method of assaying the content of DBM particles, by weight, in a bone implant material are also provided.
Ulk1 Compositions, Inhibitors, Screening And Methods Of Use
Dr. Egan graduated from the George Washington University School of Medicine and Health Science in 1996. He works in Alpine, UT and specializes in Family Medicine. Dr. Egan is affiliated with American Fork Hospital and Timpanogos Regional Hospital.